The rising global burden of osteoporosis: insights into prevalence, fracture rates, and future trends

Authors

  • Vijayakumar S. Department of Pharmacy Practice, Srivijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri, Tamil Nadu, India https://orcid.org/0000-0002-9339-5931
  • Parimalakrishnan S. Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu, India https://orcid.org/0000-0003-3832-0950
  • Prem Anand D. C. St. Peter’s Pharmacy College and Research Institute, Hosur, Krishnagiri district, Tamil Nadu, India
  • Monisha S. Department of Pharmacy Practice, Srivijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri, Tamil Nadu, India
  • Vishnuvarthini Department of Pharmacy Practice, Srivijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri, Tamil Nadu, India
  • Vijayakumar A. R. Faculty of Pharmacy, Sree Balaji Medical College and Hospital, BIHER, Chromepet, Chennai, Tamil Nadu, India https://orcid.org/0000-0002-1841-3167

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20251847

Keywords:

Osteoporosis, Bone density, Fracture risk, Estrogen

Abstract

Osteoporosis is a global health concern, marked by reduced bone density and increased fracture of risk, which unfavorably impacts quality of life and results substantial burdens on healthcare systems. This condition often progresses asymptomatically, with fractures, functional decline, and rise in mortality emerging in advanced stages. However, projections indicate that by 2050, over 50% of global osteoporotic fractures will occur in Asia, highlighting the urgency for targeted interventions. Early detection is very crucial for mitigating osteoporosis-associated morbidity. Screening programs enable timely identification of at-risk individuals, may facilitating interventions such as pharmacological therapy and lifestyle modifications that significantly lower the fracture incidence. Furthermore, community-based awareness campaigns may be playing a critical role in promoting bone health by encouraging sufficient intake of calcium and vitamin D supplement, in-addition regular to do physical activity. A life-course approach to bone health is essential. In postmenopausal women, pharmacological and non-pharmacological treatments, lifestyle strategies are imperative for decline bone loss and preventing bone fractures. To achieve optimal bone mineral density (BMD) and postpone the onset of disease, premenopausal women must receive early preventive measure care and proper education. However, substantial rise in the prevalence of osteoporosis worldwide suggests to improve awareness among the public, expand access to healthcare, and create all-encompassing prevention and management plans. In order to lessen the significant societal and economic effects of this silent epidemic, multidisciplinary collaboration and continuing public health initiatives are essential.

Metrics

Metrics Loading ...

References

Velmishi V, Troja E, Tanka M, Bali D, Dervishi E, et al. Skeletal manifestations, bone pain, and BMD changes in Albanian type 1 Gaucher patients treated with taliglucerase alfa. J Osteoporos. 2023;2023:3254533. DOI: https://doi.org/10.1155/2023/3254533

Vijayakumar R, Büsselberg D. Osteoporosis: an under-recognized public health problem. J Local Glob Health Sci. 2016;1(2):1-13. DOI: https://doi.org/10.5339/jlghs.2016.2

Yue YS, Liu Y, Lu K, Shi Q. Outdoor walking, genetic predisposition, and the risk of incident osteoporosis among older adults: a prospective large population-based cohort study. Osteoporos Int. 2024;35(4):1249-59. DOI: https://doi.org/10.1007/s00198-024-07122-4

Tardi P, Szilagyi B, Makai A, Gyuro M. The development of a reliable and valid instrument to measure osteoporosis-related knowledge: validation of the Hungarian version of osteoporosis knowledge assessment tool (OKAT). BMC Public Health. 2023;23(1):1515-20.

Gallagher JC, Tella SH. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2013;142:155-70. DOI: https://doi.org/10.1016/j.jsbmb.2013.09.008

Broderick JM, Bruce-Brand R, Stanley E, Mulhall KJ. Osteoporotic hip fractures: the burden of fixation failure. Injury. 2013;44(1):1-4. DOI: https://doi.org/10.1155/2013/515197

Lydick E, Martin A, Yawn B. Impact of fears on quality of life in patients with a silent disease: osteoporosis. Osteoporos Int. 2007;18(6):1307-15. DOI: https://doi.org/10.1016/S0149-2918(96)80084-1

Díez-Pérez A, Hooven FH, Adachi JD, Adami S. Regional differences in treatment for osteoporosis: the global longitudinal study of osteoporosis in women (GLOW). Bone. 2011;49(3):493-8. DOI: https://doi.org/10.1016/j.bone.2011.05.007

Chakhtoura M, Dagher H, Sharara S, Ajjour S. Systematic review of major osteoporotic fracture to hip fracture incidence rate ratios worldwide: implications for fracture risk assessment tool (FRAX)-derived estimates. J Bone Miner Res. 2021;36(10):1942-56. DOI: https://doi.org/10.1002/jbmr.4395

Shen Y, Huang X, Wu J, Lin X, Xiling L, Xiao Z, Zhiang Z, et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990–2019. Front Endocrinol (Lausanne). 2022;13:882241. DOI: https://doi.org/10.3389/fendo.2022.882241

Agten CA, Ramme AJ, Kang S, Honig S, Chang G. Cost-effectiveness of virtual bone strength testing in osteoporosis screening programs for postmenopausal women in the United States. Radiology. 2017;285(2):506-17. DOI: https://doi.org/10.1148/radiol.2017161259

Ali M, Uddin Z, Hossain A. Prevalence and patterns of risk of osteoporosis in Bangladeshi adult population: an analysis of calcaneus quantitative ultrasound measurements. Osteology. 2021;1(1):187-96. DOI: https://doi.org/10.3390/osteology1040018

Lindsay R. Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumatol. 1993;7(3):499-513. DOI: https://doi.org/10.1016/S0950-3579(05)80075-5

Wang L, You X, Zhang L, Zhang C, Changqing Z, Weiguo Z. Mechanical regulation of bone remodeling. Bone Res. 2022;10(1):16. DOI: https://doi.org/10.1038/s41413-022-00190-4

Iwaniec UT, Turner RT. Influence of body weight on bone mass, architecture, and turnover. J Endocrinol. 2016;230(3):R115-30. DOI: https://doi.org/10.1530/JOE-16-0089

Kovács I, Kovács K, Gerván P, Utczás K, Katinka U, Gyöngyi O, Zsófia T, et al. Ultrasonic bone age fractionates cognitive abilities in adolescence. Sci Rep. 2022;12(1):5311. DOI: https://doi.org/10.1038/s41598-022-09329-z

Hjalmarson HV, Straudmark M, Klaëssbo P. Healthy risk awareness motivates fracture prevention behaviour: a grounded theory study of women with osteoporosis. Int J Qual Stud Health Well-being. 2007;2(3):236. DOI: https://doi.org/10.1080/17482620701436939

Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res. 2006;443:19-24. DOI: https://doi.org/10.1097/01.blo.0000200248.34876.fe

Parimalakrishnan S, Anand DC, Fareedullah M, Vijayakumar S. Assessing health-related quality of life in osteoporosis patients in India: a cross-sectional study of fractures in rural and urban populations. Korean J Physiol Pharmacol. 2024;28(1):241-51.

Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: a review. J Womens Health (Larchmt). 2014;23(7):563-73. DOI: https://doi.org/10.1089/jwh.2013.4611

Das S, Crockett JC. Osteoporosis: a current view of pharmacological prevention and treatment. Drug Des Devel Ther. 2013;7:435-48. DOI: https://doi.org/10.2147/DDDT.S31504

Vijayakumar S, Parimalakrishnan S, Vijayakumar AR, Yeshwanthkumar BA. Prospective interventional study on combination of calcium carbonate and vitamin D3 in osteoporosis patients: an open-label trial. Eur Chem Bull. 2023;12(1):2789-97.

Haq SA. Treatment of osteoporosis: facing the challenges in the Asia-Pacific region. Int J Rheum Dis. 2008;11(4):327-34. DOI: https://doi.org/10.1111/j.1756-185X.2008.00395.x

McCloskey E, Rathi J, Heijmans S, Blagden M. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int. 2021;32(2):251-9. DOI: https://doi.org/10.1007/s00198-020-05557-z

Czerwinski E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J, et al. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation (IOF). Ortop Traumatol Rehabil. 2007;9(6):337-56.

Vijayakumar S, Parimalakrishnan S, Anand DC, Poornima S. Assessing osteoporosis knowledge levels among students and the public using the OKAT questionnaire: a prospective study. Int J Res Pharm Sci. 2020;11(4):1-9.

Dastmanesh S, Karimi M, Ghahremani L, Seif M, Mozhgan S, Elahe Z. A health communication campaign for prevention of osteoporosis in rural elderly women. Int J Public Health. 2023;23(1):124-32. DOI: https://doi.org/10.1186/s12905-023-02282-7

Shaji H, Cecily J. Early detection and prevention of osteoporosis among pre- and postmenopausal women in Saudi Arabia. J Health Sci. 2018;29(1):687-97. DOI: https://doi.org/10.1177/1054773818769209

Bertoldo F, Cianferotti L, Di Monaco M, Falchetti A, Alberto F, Fassio A, Gatti D, et al. Definition, assessment, and management of vitamin D inadequacy: suggestions, recommendations, and warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients. 2022;14(19):4148. DOI: https://doi.org/10.3390/nu14194148

Millen AE, Bodnar LM. Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr. 2008;87(4):1102S-5. DOI: https://doi.org/10.1093/ajcn/87.4.1102S

Downloads

Published

2025-06-24

How to Cite

S., V., S., P., D. C., P. A., S., M., Vishnuvarthini, & A. R., V. (2025). The rising global burden of osteoporosis: insights into prevalence, fracture rates, and future trends. International Journal of Basic & Clinical Pharmacology, 14(4), 603–613. https://doi.org/10.18203/2319-2003.ijbcp20251847

Issue

Section

Review Articles